Background illustration for clinical trials search

Paid Clinical Trials Calgary

Discover 524 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Calgary, Issaquah WA, Edmonds WA, Seattle WA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Calgary, Eugene OR, Walnut Creek CA, San Francisco CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase3, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Calgary, Seattle WA, Portland OR, Salt Lake City UT,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

for
Breast Cancer
Location: Calgary, Kelowna, Vancouver, Hamilton, Toronto, Ottawa,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 0+

Code: NCT05601440

Phase2, Recruiting

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

for
Metastatic Castration-resistant Prostate Cancer,
Location: Calgary, Edmonton, Saskatoon, Regina, Vancouver, London,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06439225

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Calgary, Seattle WA, Portland OR, Eugene OR,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase2, Recruiting

Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma

for
Gastroesophageal Adenocarcinoma
Location: Calgary, Saskatoon, Regina, Vancouver, Winnipeg, London,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06043427

Phase2, Recruiting

A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma

for
Esophageal Cancer
Location: Calgary
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18 - 70+

Code: NCT05370144

Recruiting

Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer

for
Advanced Head and Neck Cancer
Location: Calgary, Edmonton, Vancouver, Winnipeg, Toronto, Ottawa,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06641791

Phase3, Recruiting

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

for
Alveolar Soft Part Sarcoma, Renal Cell Carcinoma,
Location: Calgary, Toronto
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 15+

Code: NCT07297667

Phase1, Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Calgary, Vancouver, Portland OR, Salt Lake City UT,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase3, Recruiting

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

for
Pneumonitis, Immune-related Adverse Event
Location: Calgary
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT06860542

Phase2, Recruiting

Steroid Sparing in Immune Related Hepatitis (irH)

for
Hepatitis Immune
Location: Calgary
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05345847

Recruiting

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

for
Renal Cell Carcinoma
Location: Calgary, San Antonio TX, Nashville TN, Philadelphia PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07195682

Phase1, Recruiting

STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Calgary, Kelowna, Saskatoon, Vancouver, London,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06880523

Phase2, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Calgary, Vancouver, Vancouver WA, Happy Valley OR,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase3, Recruiting

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

for
Non-Small Cell Lung Cancer
Location: Calgary, Portland OR, Reno NV, Edwards CO, Orange CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07100080

Phase2, Phase3, Recruiting

PROMIS and Mobility Evaluation in Sarcoma Patients

for
Sarcoma, Giant Cell Tumor of Bone
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT07227961

Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Calgary, Seattle WA, Portland OR, Reno NV,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase2, Phase3, Recruiting

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Calgary, Toronto, Houston TX, Birmingham AL,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06988488

Phase1, Phase2, Recruiting